Roxanne Ally

Title: Roxanne Ally: Innovator in Neurodegenerative Disease Research

Introduction

Roxanne Ally is a prominent inventor based in Briarwood, NY (US). She has made significant contributions to the field of neurodegenerative disease research. Her work focuses on developing non-human animal models that can help in understanding and treating conditions such as amyotrophic lateral sclerosis (ALS) and frontotemporal dementia (FTD).

Latest Patents

Roxanne Ally holds a patent for a groundbreaking invention titled "Non-human animals having a hexanucleotide repeat expansion in a C9ORF72 locus." This patent describes a non-human animal model, such as a rodent, that incorporates a heterologous hexanucleotide repeat (GGGGCC) in an endogenous C9ORF72 locus. The model is designed to exhibit characteristics associated with neurodegenerative disorders, providing a valuable tool for identifying therapeutic candidates that may prevent, delay, or treat these diseases.

Career Highlights

Roxanne Ally is currently employed at Regeneron Pharmaceuticals, Inc., where she continues her research in neurodegenerative diseases. Her innovative approach and dedication to her work have positioned her as a key figure in her field. With a patent portfolio that includes 1 patent, she is making strides in advancing our understanding of complex neurological conditions.

Collaborations

Roxanne has collaborated with notable colleagues, including David Heslin and Chia-Jen Siao. These partnerships have enhanced her research efforts and contributed to the development of effective models for studying neurodegenerative diseases.

Conclusion

Roxanne Ally's contributions to neurodegenerative disease research through her innovative patent and collaborations highlight her role as a leading inventor in this critical field. Her work promises to pave the way for new therapeutic strategies that could significantly impact the lives of those affected by these disorders.